Exscientia and Recursion Merge to Form AI Drug Discovery Giant

Exscientia Merges with Recursion: Creating an AI Superpower in Drug Discovery

The pharmaceutical landscape is witnessing a significant shake-up as Exscientia, a pioneering force in AI-driven drug discovery, merges with Recursion, a leader in biological exploration and translation. This merger promises to form a formidable entity in the AI drug discovery space, potentially revolutionizing how new medicines are developed.